Alison Brown , Valerie Delpech, Anne Presanis, Gary Murphy and Noel Gill.

11
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV transmission among MSM has not been reached despite high treatment uptake Alison Brown , Valerie Delpech, Anne Presanis, Gary Murphy and Noel Gill.

description

The threshold for an ART secondary prevention effect on HIV transmission among MSM has not been reached despite high treatment uptake. Alison Brown , Valerie Delpech, Anne Presanis, Gary Murphy and Noel Gill. . Background :. - PowerPoint PPT Presentation

Transcript of Alison Brown , Valerie Delpech, Anne Presanis, Gary Murphy and Noel Gill.

Page 1: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

The threshold for an ART secondary prevention effect on HIV

transmission among MSM has not been reached despite high treatment

uptake

Alison Brown, Valerie Delpech, Anne Presanis, Gary Murphy and

Noel Gill.

Page 2: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

Background:

• Viral load established as key predictor for HIV transmission; ART effective at individual level

• From promise to programmes: the challenge of the treatment cascade

In the UK:• MSM HIV prevalence 5% and sustained number of

HIV diagnoses • HIV care provided free of charge • Nearly all diagnosed MSM are in HIV care • 82% of MSM in HIV care receive treatment

Page 3: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

Aims:

Assess the impact of high ART coverage on HIV transmission among MSM through:

•Community viral load •Number/proportion of population who are infective (viral load >1500 copies)•Markers of HIV incidence

Page 4: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

Methods:• Observational study of HIV-infected MSM

in the UK, 2006-2010• Comprehensive, national surveillance

data and modelling techniques determined:• Number HIV+ MSM (diagnosed and

undiagnosed)• ART coverage• Number & proportion of HIV-infected MSM who

were infective (viral load >1500 copies/mL)• HIV incidence indicators and the estimated

number of infective MSM

Page 5: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

Number of HIV positive MSM,and proportion

diagnosed and treated UK: 2006-10

.0005000.000

10000.00015000.00020000.00025000.00030000.00035000.00040000.00045000.000 Undiagnosed Diagnosed and untreated

Diagnosed and treated

Num

ber l

ivin

g wi

th H

IV

75%

77%

71%

80%

71%

Page 6: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

Number of HIV-infected MSM, and proportion infective (VL>1500

copies) by diagnostic and treatment status, UK: 2010

CD4<

350

CD4

350-

500

CD4

>50

0

Undi-ag-

nosed

Diagnosed

Diagnosed and untreated Treated

0tan28a5660280tan6a56736

0tan16a5687160tan25a570125

0tan6a571560tan15a5728150tan25a574225

Infective

Non-infective

Undiagnosed MSM assumed to have same distribution of viral load as untreated MSM in their first year of dia-gnosis

Page 7: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

Distribution of infective MSM * among HIV-infected MSM, UK:

2010

0tan29a5665290tan28a566028

0tan6a567360tan16a5687160tan25a570125

0tan6a571560tan15a5728150tan25a574225

0tan4a575640tan14a576914

35%

Infectious Non infectious

Num

ber o

f MSM

livi

ng w

ith

HIV

in

fect

ion

Breakdown of the infectious population

Undiagnosed MSM assumed to have same distribution of viral load as untreated MSM in their first year of dia-gnosis

Treated5%

Untreated >50016%

Untreated 350-50012%

Untreated <3505%

Undiagnosed62%

Page 8: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

Annual HIV incidence in MSM, England & Wales: 2001-2010 (Birrell

et al.)

Page 9: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

Annual HIV incidence in MSM, England & Wales: 2001-2010 (Birrell

et al.)

Also, between 2006-2010:- Number of new diagnoses increased- Median age & CD4 count at diagnosis stable - 25% of MSM newly diagnosed were recently infected (2009-10)

Page 10: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

Why is HIV transmission continuing?

.0005000.000

10000.00015000.00020000.00025000.00030000.00035000.00040000.00045000.000 Undiagnosed

Diagnosed and untreatedDiagnosed and treated

Num

ber l

ivin

g wi

th H

IV

Treated5%

Untreated >50016%

Untreated 350-50012%

Untreated <3505%

Undiagnosed62%

And…

And…in 2010 only 15-25% of MSM had an HIV test

Page 11: Alison Brown , Valerie Delpech,  Anne Presanis, Gary Murphy and Noel Gill.

HIV and STI Department, Health Protection Agency - Colindale

HIV and AIDS Reporting System

Conclusions:• UK access to HIV testing and treatment is excellent• Despite very high ART coverage, HIV

transmission has not decreased among MSM

• HIV incidence probably would have been much higher without extensive ART coverage

• Undiagnosed probable source of most new infections• Higher rates of testing are required to reduce late

diagnoses• Primary prevention remains key – Safer sex campaigns and behavioural interventions– Role of partner notification needs expanding